Beauty Health (SKIN) Competitors $0.95 +0.01 (+0.74%) As of 11:31 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SKIN vs. BBNX, TMCI, DCTH, NPCE, SMLR, CLPT, TCMD, NNOX, SMTI, and ZIMVShould you be buying Beauty Health stock or one of its competitors? The main competitors of Beauty Health include Beta Bionics (BBNX), Treace Medical Concepts (TMCI), Delcath Systems (DCTH), NeuroPace (NPCE), Semler Scientific (SMLR), ClearPoint Neuro (CLPT), Tactile Systems Technology (TCMD), Nano-X Imaging (NNOX), Sanara MedTech (SMTI), and ZimVie (ZIMV). These companies are all part of the "medical equipment" industry. Beauty Health vs. Beta Bionics Treace Medical Concepts Delcath Systems NeuroPace Semler Scientific ClearPoint Neuro Tactile Systems Technology Nano-X Imaging Sanara MedTech ZimVie Beauty Health (NASDAQ:SKIN) and Beta Bionics (NASDAQ:BBNX) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, valuation, dividends, profitability, institutional ownership, community ranking, media sentiment, earnings and analyst recommendations. Do insiders & institutionals believe in SKIN or BBNX? 93.3% of Beauty Health shares are owned by institutional investors. 41.0% of Beauty Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Does the media refer more to SKIN or BBNX? In the previous week, Beauty Health had 15 more articles in the media than Beta Bionics. MarketBeat recorded 16 mentions for Beauty Health and 1 mentions for Beta Bionics. Beauty Health's average media sentiment score of 1.02 beat Beta Bionics' score of 0.00 indicating that Beauty Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Beauty Health 12 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Beta Bionics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts rate SKIN or BBNX? Beauty Health presently has a consensus price target of $2.50, indicating a potential upside of 162.33%. Beta Bionics has a consensus price target of $24.83, indicating a potential upside of 129.51%. Given Beauty Health's higher probable upside, research analysts clearly believe Beauty Health is more favorable than Beta Bionics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Beauty Health 1 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00Beta Bionics 0 Sell rating(s) 3 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.78 Which has higher earnings and valuation, SKIN or BBNX? Beta Bionics has lower revenue, but higher earnings than Beauty Health. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBeauty Health$334.29M0.36-$100.12M-$0.43-2.22Beta Bionics$65.12M7.20N/AN/AN/A Is SKIN or BBNX more profitable? Beta Bionics has a net margin of 0.00% compared to Beauty Health's net margin of -8.11%. Beta Bionics' return on equity of 0.00% beat Beauty Health's return on equity.Company Net Margins Return on Equity Return on Assets Beauty Health-8.11% -44.83% -3.54% Beta Bionics N/A N/A N/A Does the MarketBeat Community favor SKIN or BBNX? Beauty Health received 34 more outperform votes than Beta Bionics when rated by MarketBeat users. However, 66.67% of users gave Beta Bionics an outperform vote while only 45.45% of users gave Beauty Health an outperform vote. CompanyUnderperformOutperformBeauty HealthOutperform Votes4045.45% Underperform Votes4854.55% Beta BionicsOutperform Votes666.67% Underperform Votes333.33% SummaryBeta Bionics beats Beauty Health on 8 of the 15 factors compared between the two stocks. Get Beauty Health News Delivered to You Automatically Sign up to receive the latest news and ratings for SKIN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SKIN vs. The Competition Export to ExcelMetricBeauty HealthSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$120.74M$4.24B$5.39B$7.63BDividend YieldN/A46.48%5.44%4.33%P/E Ratio-2.3028.9222.0918.17Price / Sales0.3649.80391.22105.10Price / CashN/A51.0838.2034.62Price / Book1.996.076.764.19Net Income-$100.12M$67.64M$3.21B$247.59M7 Day Performance12.67%3.31%4.53%4.95%1 Month Performance-32.41%-10.12%-6.55%-4.69%1 Year Performance-69.75%23.21%15.81%3.76% Beauty Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SKINBeauty Health1.8324 of 5 stars$0.95+0.7%$2.50+162.3%-70.6%$120.74M$334.29M-2.301,030Positive NewsGap UpBBNXBeta BionicsN/A$10.46-4.1%$24.83+137.4%N/A$453.43M$65.12M0.00294Gap UpTMCITreace Medical Concepts2.8003 of 5 stars$6.76+0.3%$9.93+46.9%-40.8%$425.14M$209.36M-6.83250News CoverageGap UpDCTHDelcath Systems3.1551 of 5 stars$11.59+8.7%$22.75+96.3%+113.6%$387.49M$37.21M-8.5960News CoveragePositive NewsGap UpNPCENeuroPace3.2205 of 5 stars$10.67+2.4%$15.20+42.5%-21.8%$347.42M$79.91M-10.67170SMLRSemler Scientific2.6059 of 5 stars$34.26+1.5%$71.00+107.2%+26.5%$328.79M$56.29M6.98120Short Interest ↑News CoveragePositive NewsCLPTClearPoint Neuro2.1946 of 5 stars$11.54+0.6%$25.00+116.6%+141.9%$318.87M$31.39M-16.72110News CoveragePositive NewsGap UpTCMDTactile Systems Technology3.3885 of 5 stars$13.40+1.0%$18.00+34.3%-3.7%$317.12M$292.98M19.14980Positive NewsNNOXNano-X Imaging1.6943 of 5 stars$4.74+2.8%$12.00+153.2%-45.2%$273.87M$11.28M-5.58190SMTISanara MedTech1.7452 of 5 stars$29.96+3.1%$48.50+61.9%-7.3%$266.70M$86.67M-30.2660News CoverageZIMVZimVie2.5798 of 5 stars$9.44+3.2%$19.50+106.6%-41.6%$262.88M$449.75M-0.722,700Positive NewsGap Up Related Companies and Tools Related Companies BBNX Alternatives TMCI Alternatives DCTH Alternatives NPCE Alternatives SMLR Alternatives CLPT Alternatives TCMD Alternatives NNOX Alternatives SMTI Alternatives ZIMV Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SKIN) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | SponsoredA Biotech Power Move? This company is leading the charge in developing advanced antiviral therapies—watch closely!With a revolutionary antiviral drug, this company is in a great position to build shareholder value as this ti...Smallcaps Daily | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredWhat President Trump’s Executive Order 14154 means for your moneyNearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Beauty Health Company Please log in to your account or sign up in order to add this asset to your watchlist. Share Beauty Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.